戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tivation of PI 3-kinase in the presence of a beta adrenergic receptor antagonist.
2 etimes increased by treatment with IL-4 or a beta-adrenergic receptor antagonist.
3 macrophages were prevented by propranolol, a beta-adrenergic receptor antagonist.
4                            Pretreatment with beta-adrenergic receptor antagonists abolished differenc
5  of critical poisoning from benzodiazepines, beta-adrenergic receptor antagonists (also known as beta
6                   Further, both propranolol (beta-adrenergic receptor antagonist) and prazosin (alpha
7                              For many years, beta-adrenergic receptor antagonists (beta-blockers or b
8                                              beta-Adrenergic receptor antagonists (beta-blockers) are
9  CHF patients have shown that treatment with beta-adrenergic receptor antagonists (betaB) improves ca
10                   The data also suggest that beta-adrenergic receptor antagonists can attenuate LPS-i
11 e expression, but pre-exposure to timolol, a beta-adrenergic receptor antagonist, delayed this effect
12 r antagonist, or propranolol, a nonselective beta-adrenergic receptor antagonist, delivered by osmoti
13 y was prevented with either LTCC blockers or beta-adrenergic receptor antagonists, demonstrating a pr
14                    Furthermore, DA D1/D5 and beta-adrenergic receptor antagonists disrupted behavior,
15                          Pretreatment with a beta-adrenergic receptor antagonist, esmalol, had no eff
16                                              Beta adrenergic receptor antagonists greatly reduce reac
17                               More recently, beta-adrenergic receptor antagonists have been found to
18 hese responses can be inhibited by alpha and beta-adrenergic receptor antagonists implying a bacteria
19        Most clinical studies have shown that beta-adrenergic receptor antagonists improve long-term s
20                                  Orthosteric beta-adrenergic receptor antagonists, known as beta-bloc
21                      Systemic application of beta-adrenergic receptor antagonists may have detrimenta
22                     Here, we asked whether a beta-adrenergic receptor antagonist might interfere with
23 in precursor, or with S(-) pindolol, a 5HT1A/beta adrenergic receptor antagonist or with LY206130, a
24                Intraamygdala injections of a beta-adrenergic receptor antagonist or agonist, each tim
25 s in Thy-1 mRNA levels were prevented by the beta-adrenergic receptor antagonist propranolol (10 micr
26 ug or 30 mug) or vehicle (Experiment 1), the beta-adrenergic receptor antagonist propranolol (2 mug)
27 M) blocked the effects of NA on Ito, but the beta-adrenergic receptor antagonist propranolol (20 micr
28                 We probed the effects of the beta-adrenergic receptor antagonist propranolol (40 mg)
29           We find that administration of the beta-adrenergic receptor antagonist propranolol before m
30   Healthy participants were administered the beta-adrenergic receptor antagonist propranolol or a pla
31 ntrast, treatment before hemorrhage with the beta-adrenergic receptor antagonist propranolol was asso
32                                          The beta-adrenergic receptor antagonist propranolol, adminis
33 y the D2 antagonist spiperone but not by the beta-adrenergic receptor antagonist propranolol.
34 and absence of a alpha2-agonist (clonidine), beta-adrenergic receptor antagonist (propranolol), and b
35                                 Although the beta-adrenergic receptor antagonist (-)-propranolol bind
36                Propranolol is a nonselective beta-adrenergic receptor antagonist that is efficacious
37 herapies is also enhanced by administering a beta-adrenergic receptor antagonist to mice housed at 22